Merlin Crossley/X
Aug 21, 2026, 21:29
Merlin Crossley: Atomic Precision in Sickle Cell Care – Structural Targeting for Fetal Globin Reactivation
Merlin Crossley, Deputy Vice-Chancellor Academic Quality at UNSW, shared a post on LinkedIn:
“Precision Medicine: Progress in science often comes from increasing precision.
In medicine precision improves diagnosis and treatment.
In my field – Sickle Cell Anemia – we now have a molecular understanding of the problem and atomic level treatments are being explored.
This is my latest commentary in the journal Blood about targeting protein domains to boost fetal globin repression.
At UNSW we are committed to Precision and Computational Medicine and believe that connecting our strengths in computing, engineering, molecular biology, and health will help drive further progress!”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 21:58Toby Richards: WEHI Trial Solidifies IV Iron as Third-Trimester Standard
-
Aug 21, 2026, 21:51Mehak Trehan: From Reading the Chapter to Writing One
-
Aug 21, 2026, 21:38Ann Reilly: Navigating Postoperative vs. Acute Blood Loss Anemia – A CDI Case Study
-
Aug 21, 2026, 19:09Aphisit Thongthaisin: Admitted to Sorbonne University’s T2H University Diploma for 2026/2027
-
Aug 21, 2026, 19:07José Luis Ferreiro Gutiérrez: Proud to Be Elected Chairperson-Elect of the ESC Working Group on Thrombosis
-
Aug 21, 2026, 19:00Manuel Monreal: New RIETE Registry Data on VTE Recurrence and Bleeding During Anticoagulation
-
Aug 21, 2026, 18:39Ronak H. Mistry: Updated ASH ITP Guidelines Bring New Guidance for Managing ITP
-
Aug 21, 2026, 18:22Ahmed Bennis: NOAC Use Is Associated With Slower Cognitive Decline in AF and Alzheimer’s Disease
-
Aug 21, 2026, 18:12Irtiza Hasan: AI-Predicted Erythropoietin Dosing Matches Physician-Guided Dosing